Canakinumab doesn't prevent prediabetes from progressing to diabetes
The anti-inflammatory drug canakinumab had no effect on rates of newly diagnosed diabetes in people who had prediabetes (elevated blood sugar levels at risk of developing into diabetes), according to research presented at ...
Mar 12, 2018